Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Efficacy and safety of canagliflozin in patients with type 2 diabetes and stage 3 nephropathy.

Yamout H, Perkovic V, Davies M, Woo V, de Zeeuw D, Mayer C, Vijapurkar U, Kline I, Usiskin K, Meininger G, Bakris G. Efficacy and safety of canagliflozin in patients with type 2 diabetes and stage 3 nephropathy. Am J Nephrol. 2014; 40(1):64-74.

View in: PubMed

collapse authors with profiles